Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EUZ.F
- Price
- 51.95
- Stock movement down
- -3.30 (-5.97%)
- Company name
- Eckert & Ziegler Strahlen- und Medizintechnik AG
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 1.08B
- Ent value
- 1.23B
- Price/Sales
- 3.96
- Price/Book
- 4.35
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 32.40
- Forward P/E
- 29.35
- PEG
- -
- EPS growth
- 9.65%
- 1 year return
- 41.63%
- 3 year return
- -1.28%
- 5 year return
- 9.12%
- 10 year return
- 25.49%
Last updated: 2025-04-05
DIVIDENDS
EUZ.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 32.40 |
| Price to OCF | 23.50 |
| Price to FCF | 47.84 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.96 |
| Price to Book | 4.35 |
| EV to Sales | 4.49 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 20.85M |
| EPS (TTM) | 1.60 |
| FCF per share (TTM) | 1.09 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 273.50M |
| Gross profit (TTM) | 131.98M |
| Operating income (TTM) | 57.30M |
| Net income (TTM) | 33.42M |
| EPS (TTM) | 1.60 |
| EPS (1y forward) | 1.77 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 48.26% |
| Operating margin (TTM) | 20.95% |
| Profit margin (TTM) | 12.22% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 76.63M |
| Net receivables | 51.15M |
| Total current assets | 265.91M |
| Goodwill | 37.43M |
| Intangible assets | 15.92M |
| Property, plant and equipment | 117.60M |
| Total assets | 471.94M |
| Accounts payable | 5.34M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 91.47M |
| Total liabilities | 222.88M |
| Shareholder's equity | 249.06M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 46.08M |
| Capital expenditures (TTM) | 25.28M |
| Free cash flow (TTM) | 22.64M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 13.42% |
| Return on Assets | 7.08% |
| Return on Invested Capital | 12.55% |
| Cash Return on Invested Capital | 8.50% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 52.90 |
| Daily high | 53.65 |
| Daily low | 51.95 |
| Daily Volume | 0K |
| All-time high | 138.00 |
| 1y analyst estimate | 56.50 |
| Beta | 1.33 |
| EPS (TTM) | 1.60 |
| Dividend per share | - |
| Ex-div date | 27 Jun 2024 |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| EUZ.F | S&P500 | |
| Current price drop from All-time high | -62.36% | -12.44% |
| Highest price drop | -97.99% | -56.47% |
| Date of highest drop | 3 Jan 2003 | 9 Mar 2009 |
| Avg drop from high | -72.12% | -11.07% |
| Avg time to new high | 64 days | 12 days |
| Max time to new high | 4939 days | 1805 days |
COMPANY DETAILS
Marketcap
1.08B
Marketcap category
Small-cap
Description
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Employees
1085
Website
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Eckert & Ziegler ( ETR:EUZ ) Full Year 2024 Results Key Financial Results Revenue: €295.9m (up 20% from FY 2023). Net...
March 29, 2025
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it has entered into an agreement for the supply...
March 24, 2025
The simplest way to invest in stocks is to buy exchange traded funds. But you can do a lot better than that by buying...
March 24, 2025
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
March 6, 2025
Key Insights Significant control over Eckert & Ziegler by individual investors implies that the general public has more...
February 18, 2025
In recent weeks, global markets have experienced significant volatility, with U.S. stocks facing pressure from AI competition fears and mixed corporate earnings results. While large-cap indices like t...
February 4, 2025
While Eckert & Ziegler SE ( ETR:EUZ ) might not have the largest market cap around , it received a lot of attention...
January 23, 2025
As the global markets navigate mixed performances and economic indicators signal caution, small-cap stocks continue to attract attention with their potential for growth amidst broader market fluctuati...
January 6, 2025
Most readers would already know that Eckert & Ziegler's (ETR:EUZ) stock increased by 5.3% over the past three months...
January 3, 2025
As global markets navigate the uncertainties surrounding the incoming Trump administration's policies, key indices like the S&P 600 for small-cap stocks have experienced notable fluctuations. Amid the...
November 22, 2024
Next page